Table 6.2

Meta-analysis of placebo controlled trials of mesalazine for maintenance of medically induced remission in Crohn’s disease

AuthorYearNumber of trialsNumber of patientsDuration (months)ResultRef section 2
Odds ratio95% CIp Value
Steinhart1994101022120.770.64 to 0.92117
Messori19948941120.470.33 to 0.67<0.001118
Camma19971013714–480.06119
Akobeng2005789712–241.000.80 to 1.24NS120